Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model-Reference-Cited by-同舟云学术

Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model

Published:2019-11-18 Issue:11 Volume:14 Page:e0224805
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bang Seung Pil,Yeon Chang Yeor,Adhikari Nirpesh^ORCID,Neupane Sanjiv^ORCID,Kim Harim,Lee Dong Cheol,Son Myeong Jin,Lee Hyun Gyo,Kim Jae-Young,Jun Jong Hwa^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. TFOS DEWS II Definition and Classification Report;JP Craig;Ocul Surf,2017

2. Desiccating stress induces T cell-mediated Sjogren’s Syndrome-like lacrimal keratoconjunctivitis;JY Niederkorn;J Immunol,2006

3. Desiccating stress induces CD4+ T-cell-mediated Sjogren’s syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gamma;X Zhang;Am J Pathol,2011

4. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients;SY Lee;Am J Ophthalmol,2013

5. TFOS DEWS II pathophysiology report;AJ Bron;Ocul Surf,2017

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of cyclosporine nanoemulsion eye drops in patients with mild-to-moderate dry eyes: objective and subjective evaluation;BMC Ophthalmology;2024-09-09

2. Nanomedicines for Dry Eye Syndrome: Targeting Oxidative Stress with Modern Nanomaterial Strategies;Molecules;2024-08-07

3. Solid self-nanoemulsifying drug delivery systems of nimodipine: development and evaluation;Future Journal of Pharmaceutical Sciences;2024-07-10

4. Triamcinolone-loaded self nano-emulsifying drug delivery systems for ocular use: An alternative to invasive ocular surgeries and injections;International Journal of Pharmaceutics;2024-03

5. Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks;Heliyon;2024-01